Printer Friendly

CROP GENETICS LICENSES NEW BIOPESTICIDE TECHNOLOGIES; COMPANY'S TECHNOLOGY BASE EXPANDED TO NEMATICIDES

 CROP GENETICS LICENSES NEW BIOPESTICIDE TECHNOLOGIES;
 COMPANY'S TECHNOLOGY BASE EXPANDED TO NEMATICIDES
 HANOVER, Md., Oct. 23 /PRNewswire/ -- Crop Genetics International (NASDAQ: CROP) today announced the signing of an exclusive license agreement for patented biopesticide technologies to control plant parasitic nematodes.
 Crop Genetics acquired the rights to the environmentally compatible technologies from the U.S. Department of Agriculture. The technologies include unique pheromones and specific biocontrol agents which are used in combinations to attract and kill soil-dwelling nematodes. Plant parasitic nematodes are microscopic roundworms that attack major agricultural crops, such as soybeans and high value vegetables, causing major yield losses.
 Dr. Peter Carlson, chief scientist at Crop Genetics, said the company had been testing bionematicidal combinations for the past two years under a Cooperative Research And Development Agreement with the USDA's Agricultural Research Service. "We will need several seasons to fully develop this bionematicide," said Carlson, "but our field trials were sufficiently promising to justify acquiring the exclusive rights to these technologies." Under the licensing agreement, Crop Genetics will pay royalties to the USDA on sales of the bionematicide to growers.
 "It is very exciting to work towards an environmentally acceptable solution to such a persistent and devastating agriculture pest," said Dr. Michael Dimock, project coordinator for this project at Crop Genetics. Nematode pests cause millions of dollars of crop damage annually by attacking plant roots. Dimock explained that there is an accelerating need for environmentally safe, yet effective, nematicides since the Environmental Protection Agency has banned or restricted the use of many chemical products used for nematode control.
 Crop Genetics said it is targeting the soybean cyst nematode with its initial product. The cyst nematode is ubiquitous in the 50 million acres of soybeans planted in the United States each year and annual crop losses to the pest are estimated to be $250 million. The company also intends, it said, to use the patented technologies to develop a series of bionematicide products, targeting other pests such as the root knot nematode, a major pest in high-value vegetables.
 "CGI's commercialization strategy for all its technologies is to develop products to the point where we demonstrate economic and environmental feasibility in field trials," said CGI President Joe Kelly, "and then enter into corporate alliances to facilitate the world- wide development and marketing of the products." Kelly said the company plans to test the commercial potential of the first bionematicide product in Maryland field trials next year and then, if successful, seek a corporate partner to jointly continue field testing and commercialize various applications of the newly acquired technologies.
 Crop Genetics International is engaged in the discovery, development and commercialization of novel crop protection systems which substitute biopesticides for synthetic chemicals. The InStar(TM) Division is developing and commercializing insecticidal virus products to control a range of insect pests on major crops. The InCide(R) Division, using recombinant DNA technology, is developing plant vaccine systems to provide season-long and environmentally compatible pest control. The X-tend(TM) Division is developing herbicidal bacterial agents for broad spectrum weed control. The Kleentek(R) Division has developed and now markets disease-free, high-yielding sugarcane seed products.
 -0- 10/23/92
 /CONTACT: Todd Taylor of Crop Genetics International, 410-712-7170/
 (CROP) CO: Crop Genetics International ST: Maryland IN: SU: LIC


MK-CC -- PH020 -- 4104 10/23/92 11:22 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 23, 1992
Words:549
Previous Article:CAMBRIDGE TECHNOLOGY PARTNERS (CTP, INC.) CELEBRATES OPENING OF NEW HEADQUARTERS
Next Article:GREAT LAKES COMPLETES PURCHASE OF BAYROL
Topics:


Related Articles
NOVO NORDISK UNIT'S PATENT-CASE SETTLEMENT STRENGTHENS LEADERSHIP IN KEY BIOPESTICIDE TECHNOLOGY; R&D UNIT IS ASSIGNED SIX MYCOGEN PATENTS
BIOSYS AND SANDOZ ANNOUNCE JOINT DEVELOPMENT AGREEMENT; GOAL IS A SAFE AND EFFECTIVE VIRAL INSECTICIDE FOR CATERPILLARS THAT PLAGUE MAJOR CROPS
CROP GENETICS INTERNATIONAL RECEIVES PATENT; EUROPEAN PATENT COVERS INCIDE(TM) CONCEPT
CROP GENETICS REPORTS IMPROVED CONTROL WITH CORN BIOINSECTICIDE
ECOGEN SIGNS LICENSING AGREEMENT WITH WORLDWIDE LEADER IN INSECTICIDAL NEMATODE RESEARCH
CROP GENETICS AUGMENTS BIOPESTICIDE PRODUCTION; STREAMLINES RESEARCH OPERATIONS
ECOGEN BIOINSECTICIDE PRODUCTS REGISTERED IN CHINA; APPROVAL IS COMPANY'S FIRST IN CHINA, AN OVER $350 MILLION MARKET
BIOSYS ANNOUNCES AGREEMENT WITH ZENECA FOR BIO-PESTICIDE PRODUCTS
CALIFORNIA SUPREME COURT DENIES MONSANTO'S PETITION TO REVIEW RULING AFFIRMING MYCOGEN'S OPTIONS FOR PLANT TECHNOLOGY
Mycogen Receives U.S. Patents Covering Insect-Resistant Seed Products, Sues Monsanto, Dekalb, Delta & Pine Land for Infringement

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters